Case Reports in Pathology

Case Reports in Pathology / 2021 / Article

Corrigendum | Open Access

Volume 2021 |Article ID 9867879 | https://doi.org/10.1155/2021/9867879

Dalal Hassan, Saverio Ligato, "Corrigendum to “Localized Biphasic Malignant Peritoneal Mesothelioma with Rhabdoid Features Involving the Liver: Case Report and Review of the Literature”", Case Reports in Pathology, vol. 2021, Article ID 9867879, 1 page, 2021. https://doi.org/10.1155/2021/9867879

Corrigendum to “Localized Biphasic Malignant Peritoneal Mesothelioma with Rhabdoid Features Involving the Liver: Case Report and Review of the Literature”

Received08 May 2021
Accepted08 May 2021
Published21 Jun 2021

In the article titled “Localized Biphasic Malignant Peritoneal Mesothelioma with Rhabdoid Features Involving the Liver: Case Report and Review of the Literature” [1], the authors have mentioned some grammatical errors. These errors are corrected and highlighted in italic style as below:

In the Abstract: (i)“A final diagnosis of localized biphasic malignant peritoneal mesothelioma with rhabdoid features was rendered based on morphology and the result of immunohistochemical studies” is corrected to “A final diagnosis of localized biphasic malignant peritoneal mesothelioma with rhabdoid features was rendered based on morphology and the results of immunohistochemical studies.”(ii)“The patient progressed over the course of 6 months despite receiving adjuvant chemotherapy and immunotherapy with metastases and a decline in performance status and was transitioned to hospice” is corrected to “The patient progressed over the course of 6 months despite receiving adjuvant chemotherapy and immunotherapy with metastases and a decline in performance status and was transitioned to hospice care.”

In Introduction:

“The aim is to increase awareness of localized peritoneal mesothelioma among surgical pathologists, as they can mimic as primary or secondary hepatic tumors clinically and histologically and review the literature with regards to prognosis of these uncommon tumors” is corrected to “The aim is to increase awareness of localized peritoneal mesothelioma among surgical pathologists, as they can mimic as primary or secondary hepatic tumors clinically and histologically and review the literature with regard to prognosis of these uncommon tumors.”

In Case Presentation:

“The patient additionally received 2 doses of pembrolizumab but had a significant decline in performance status and, due to poor prognosis, was transitioned to hospice” is corrected to “The patient additionally received 2 doses of pembrolizumab but had a significant decline in performance status and, due to poor prognosis, was transitioned to hospice care.”

In the Figure 3 caption:

“(f) tumor invading colonic adventitia (g) rhabdoid component” is corrected to “(f) rhabdoid component and (g) tumor invading colonic adventitia”.

In the Figure 4 caption:

“(d) CDK53” is corrected to “(d) CK5D3.”

In Discussion and Review of the Literature:

“This is in contrast to localized peritoneal mesotheliomas, which are amendable to surgical resection [11]”, is corrected to “This is in contrast to localized peritoneal mesotheliomas, which are amenable to surgical resection [11].”

References

  1. D. Hassan and S. Ligato, “Localized Biphasic Malignant Peritoneal Mesothelioma with Rhabdoid Features Involving the Liver: Case Report and Review of the Literature,” Case Reports in Pathology, vol. 2019, Article ID 2732674, 7 pages, 2019. View at: Publisher Site | Google Scholar

Copyright © 2021 Dalal Hassan and Saverio Ligato. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views247
Downloads499
Citations

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.